In the study, we investigated the expression of lncRNA MIAT in prostate cancer, and explored whether it can affect the proliferation and apoptosis of prostate cancer cells by regulating the miR-361-3p/CCAR2 axis, so as to provide new targets for the treatment of prostate cancer. Here, CCAR2 is linked to prostate cancer.